相似文献
1
Synthesis and Characterization of a Tetramethyl Furanone Functionalized Diiminedioxime, A Potential Ligand for Cu Radiopharmaceuticals, and its Copper(II) and Nickel(II) Complexes.
Polyhedron. 2009 Mar 12;28(4):775-781. doi: 10.1016/j.poly.2008.12.006.
2
Reactivity of nickel(II) and copper(II) complexes of a β-aminohydrazone ligand with pyridine-2-aldehyde: macrocyclization vs unprecedented pyrazole ring synthesis via C-C bond-forming reaction.
Inorg Chem. 2011 Sep 5;50(17):8012-9. doi: 10.1021/ic200261j. Epub 2011 Aug 1.
3
Hydrogen bonds as structural directive towards unusual polynuclear complexes: synthesis, structure, and magnetic properties of copper(II) and nickel(II) complexes with a 2-aminoglucose ligand.
Chemistry. 2009;15(5):1261-71. doi: 10.1002/chem.200800670.
4
Synthesis, characterization, thermal behavior, and DNA-cleaving studies of cyano-bridged nickel(II)-copper(II) complexes of 4-(pyridin-2-ylazenyl)resorcinol.
Chem Biodivers. 2011 Oct;8(10):1871-9. doi: 10.1002/cbdv.201000209.
5
Macrocyclic Cu(II)(2), Cu(II)(4), Ni(II)(3), and Ni(II)(4) Complexes: Magnetic Properties of Tetranuclear Systems.
Inorg Chem. 1997 Oct 8;36(21):4656-4664. doi: 10.1021/ic9611103.
6
Copper(II) and nickel(II) complexes of beta-aminoketoxime ligand: syntheses, crystal structures, magnetism, and nickel(II) templated coupling of oxime with nitrile.
Inorg Chem. 2010 Jan 18;49(2):541-51. doi: 10.1021/ic901614p.
7
(4,4,12,12-Tetramethyl-5,8,11-triazapenta-2,14-dione 2-oxime 14-oximato-kappa(5)N)copper(II) perchlorate: a copper(II) compound with a pentadentate triamine-oxime-oximate ligand.
Acta Crystallogr C. 2004 Jun;60(Pt 6):m256-7. doi: 10.1107/S0108270104008765. Epub 2004 May 22.
8
Oxamato-bridged trinuclear Ni(II)Cu(II)Ni(II) complexes with irregular spin state structures and a binuclear Ni(II)Cu(II) complex with an unusual supramolecular structure: crystal structure and magnetic properties.
Inorg Chem. 2001 Jun 18;40(13):3134-40. doi: 10.1021/ic001023h.
9
Synthesis, characterization, and ligand exchange reactivity of a series of first row divalent metal 3-hydroxyflavonolate complexes.
Inorg Chem. 2010 Jan 4;49(1):82-96. doi: 10.1021/ic901405h.
10
Covalent linkage of the type-2 and type-3 structural mimics to model the active site structure of multicopper oxidases: synthesis and magneto- structural properties of two angular trinuclear copper(II) complexes.
Inorg Chem. 2003 Sep 8;42(18):5660-8. doi: 10.1021/ic034565i.
引用本文的文献
1
Access to Formally Ni(I) States in a Heterobimetallic NiZn System.
Chem Sci. 2013;4(1):157-163. doi: 10.1039/C2SC21231E.
2
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.
Chem Rev. 2010 May 12;110(5):2858-902. doi: 10.1021/cr900325h.
本文引用的文献
1
A short history of SHELX.
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
2
Synthesis and crystal structure of a salen-type copper(II) complex derived from 3,5'-O-dimethyl-2',3'-diamino-2',3'-dideoxy-beta-D-xylo-uridine.
Org Biomol Chem. 2005 Apr 7;3(7):1170-1. doi: 10.1039/b500785b. Epub 2005 Feb 22.
3
Synthesis and biodistribution of a Lipophilic 64Cu-labeled monocationic Copper(II) complex.
Nucl Med Biol. 2002 Apr;29(3):289-94. doi: 10.1016/s0969-8051(02)00285-8.
4
Coordination Compounds of Schiff-Base Ligands Derived from Diaminomaleonitrile (DMN): Mononuclear, Dinuclear, and Macrocyclic Derivatives.
Inorg Chem. 1996 Sep 11;35(19):5492-5499. doi: 10.1021/ic960237p.
5
Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
J Nucl Med. 1998 Jan;39(1):77-86.
6
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells.
J Nucl Med. 1996 Sep;37(9):1578-82.
7
Biochemistry of multidrug resistance mediated by the multidrug transporter.
Annu Rev Biochem. 1993;62:385-427. doi: 10.1146/annurev.bi.62.070193.002125.
8
Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Cancer Res. 1993 Mar 1;53(5):977-84.
9
Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12.
J Nucl Med. 1994 Oct;35(10):1571-80.
10
A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.
J Nucl Med. 1984 Dec;25(12):1350-5.
Zotero 插件